Nalaganje...
Impact of the gut microbiome on immune checkpoint inhibitor efficacy—a systematic review
BACKGROUND: Immune checkpoint inhibitors (icis) are increasingly being used in clinical practice, improving outcomes for cancer patients. Preclinical models showed significant interaction between the gut microbiome (gm) and response to icis. However, that interaction remains unclear in clinical prac...
Shranjeno v:
| izdano v: | Curr Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Multimed Inc.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927774/ https://ncbi.nlm.nih.gov/pubmed/31896938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.5177 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|